Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention

Purpose: The change in coronary physiology from lipid-lowering therapy (LLT) lacks an appropriate method of examination. Quantitative flow ratio (QFR) is a novel angiography-based approach allowing rapid assessment of coronary physiology. This study sought to determine the impact of low-density lipo...

Full description

Bibliographic Details
Main Authors: Long Chen, Qin Chen, Jiaxin Zhong, Zhen Ye, Mingfang Ye, Yuanming Yan, Lianglong Chen, Yukun Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.679599/full
id doaj-48f5fb3f9e7540d7b05c49b38997100f
record_format Article
spelling doaj-48f5fb3f9e7540d7b05c49b38997100f2021-06-18T06:02:22ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-06-01810.3389/fcvm.2021.679599679599Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary InterventionLong Chen0Long Chen1Long Chen2Qin Chen3Qin Chen4Qin Chen5Jiaxin Zhong6Jiaxin Zhong7Jiaxin Zhong8Zhen Ye9Zhen Ye10Zhen Ye11Mingfang Ye12Mingfang Ye13Mingfang Ye14Yuanming Yan15Yuanming Yan16Yuanming Yan17Lianglong Chen18Lianglong Chen19Lianglong Chen20Yukun Luo21Yukun Luo22Yukun Luo23Department of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, ChinaFujian Institute of Coronary Artery Disease, Fuzhou, ChinaFujian Heart Medical Center, Fuzhou, ChinaPurpose: The change in coronary physiology from lipid-lowering therapy (LLT) lacks an appropriate method of examination. Quantitative flow ratio (QFR) is a novel angiography-based approach allowing rapid assessment of coronary physiology. This study sought to determine the impact of low-density lipoprotein cholesterol (LDL-C) goal achievement on coronary physiology through QFR.Methods: Cases involving percutaneous coronary intervention (PCI) and 1-year angiographic follow-up were screened and assessed by QFR analysis. Patients were divided into two groups according to the LDL-C level at the 1-year follow-up: (1) goal-achievement group (LDL-C < 1.8 mmol/L or reduction of ≥50%, n = 146, lesion = 165) and (2) non-achievement group (n = 286, lesion = 331). All QFR data and major adverse cardiovascular and cerebrovascular events (MACCEs) at 1 year were compared between groups.Results: No differences between the groups in quantitative coronary angiography (QCA) data or QFR post-PCI were found. At the 1-year follow-up, lower percentage diameter stenosis (DS%) and percentage area stenosis (AS%) were recorded in the goal-achievement group (27.89 ± 10.16 vs. 30.93 ± 12.03, p = 0.010, 36.57 ± 16.12 vs. 41.68 ± 17.39, p = 0.003, respectively). Additionally, a better change in QFR was found in the goal-achievement group (0.003 ± 0.068 vs. −0.018 ± 0.086, p = 0.007), with a lower incidence of physiological restenosis and MACCEs (2.1 vs. 8.4%, p = 0.018, 5.4 vs. 12.6%, p = 0.021, respectively).Conclusion: Evaluated by QFR, patients who achieved the LDL-C goal appear to have a better coronary physiological benefit. This group of patients also has a better clinical outcome.https://www.frontiersin.org/articles/10.3389/fcvm.2021.679599/fullpercutaneous coronary interventionLDL—cholesterolquantative flow ratiocornoray physiologyphysiological restenosis
collection DOAJ
language English
format Article
sources DOAJ
author Long Chen
Long Chen
Long Chen
Qin Chen
Qin Chen
Qin Chen
Jiaxin Zhong
Jiaxin Zhong
Jiaxin Zhong
Zhen Ye
Zhen Ye
Zhen Ye
Mingfang Ye
Mingfang Ye
Mingfang Ye
Yuanming Yan
Yuanming Yan
Yuanming Yan
Lianglong Chen
Lianglong Chen
Lianglong Chen
Yukun Luo
Yukun Luo
Yukun Luo
spellingShingle Long Chen
Long Chen
Long Chen
Qin Chen
Qin Chen
Qin Chen
Jiaxin Zhong
Jiaxin Zhong
Jiaxin Zhong
Zhen Ye
Zhen Ye
Zhen Ye
Mingfang Ye
Mingfang Ye
Mingfang Ye
Yuanming Yan
Yuanming Yan
Yuanming Yan
Lianglong Chen
Lianglong Chen
Lianglong Chen
Yukun Luo
Yukun Luo
Yukun Luo
Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention
Frontiers in Cardiovascular Medicine
percutaneous coronary intervention
LDL—cholesterol
quantative flow ratio
cornoray physiology
physiological restenosis
author_facet Long Chen
Long Chen
Long Chen
Qin Chen
Qin Chen
Qin Chen
Jiaxin Zhong
Jiaxin Zhong
Jiaxin Zhong
Zhen Ye
Zhen Ye
Zhen Ye
Mingfang Ye
Mingfang Ye
Mingfang Ye
Yuanming Yan
Yuanming Yan
Yuanming Yan
Lianglong Chen
Lianglong Chen
Lianglong Chen
Yukun Luo
Yukun Luo
Yukun Luo
author_sort Long Chen
title Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention
title_short Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention
title_full Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention
title_fullStr Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention
title_full_unstemmed Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention
title_sort effect of low-density lipoprotein cholesterol goal achievement on vascular physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention
publisher Frontiers Media S.A.
series Frontiers in Cardiovascular Medicine
issn 2297-055X
publishDate 2021-06-01
description Purpose: The change in coronary physiology from lipid-lowering therapy (LLT) lacks an appropriate method of examination. Quantitative flow ratio (QFR) is a novel angiography-based approach allowing rapid assessment of coronary physiology. This study sought to determine the impact of low-density lipoprotein cholesterol (LDL-C) goal achievement on coronary physiology through QFR.Methods: Cases involving percutaneous coronary intervention (PCI) and 1-year angiographic follow-up were screened and assessed by QFR analysis. Patients were divided into two groups according to the LDL-C level at the 1-year follow-up: (1) goal-achievement group (LDL-C < 1.8 mmol/L or reduction of ≥50%, n = 146, lesion = 165) and (2) non-achievement group (n = 286, lesion = 331). All QFR data and major adverse cardiovascular and cerebrovascular events (MACCEs) at 1 year were compared between groups.Results: No differences between the groups in quantitative coronary angiography (QCA) data or QFR post-PCI were found. At the 1-year follow-up, lower percentage diameter stenosis (DS%) and percentage area stenosis (AS%) were recorded in the goal-achievement group (27.89 ± 10.16 vs. 30.93 ± 12.03, p = 0.010, 36.57 ± 16.12 vs. 41.68 ± 17.39, p = 0.003, respectively). Additionally, a better change in QFR was found in the goal-achievement group (0.003 ± 0.068 vs. −0.018 ± 0.086, p = 0.007), with a lower incidence of physiological restenosis and MACCEs (2.1 vs. 8.4%, p = 0.018, 5.4 vs. 12.6%, p = 0.021, respectively).Conclusion: Evaluated by QFR, patients who achieved the LDL-C goal appear to have a better coronary physiological benefit. This group of patients also has a better clinical outcome.
topic percutaneous coronary intervention
LDL—cholesterol
quantative flow ratio
cornoray physiology
physiological restenosis
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.679599/full
work_keys_str_mv AT longchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT longchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT longchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT qinchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT qinchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT qinchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT jiaxinzhong effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT jiaxinzhong effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT jiaxinzhong effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT zhenye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT zhenye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT zhenye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT mingfangye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT mingfangye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT mingfangye effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT yuanmingyan effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT yuanmingyan effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT yuanmingyan effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT lianglongchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT lianglongchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT lianglongchen effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT yukunluo effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT yukunluo effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
AT yukunluo effectoflowdensitylipoproteincholesterolgoalachievementonvascularphysiologyevaluatedbyquantitativeflowratioinpatientswhounderwentpercutaneouscoronaryintervention
_version_ 1721373344752730112